<VariationArchive VariationID="3019035" VariationName="NM_181507.2(HPS5):c.739dup (p.Glu247fs)" VariationType="Duplication" Accession="VCV003019035" Version="2" RecordType="classified" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2024-03-30" DateCreated="2024-02-29" MostRecentSubmission="2024-03-30">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3175399" VariationID="3019035">
      <GeneList>
        <Gene Symbol="HPS5" FullName="HPS5 biogenesis of lysosomal organelles complex 2 subunit 2" GeneID="11234" HGNC_ID="HGNC:17022" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p15.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="18278670" stop="18322174" display_start="18278670" display_stop="18322174" Strand="-" />
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NW_021160006.1" start="27496" stop="71101" display_start="27496" display_stop="71101" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="18300216" stop="18343720" display_start="18300216" display_stop="18343720" Strand="-" />
          </Location>
          <OMIM>607521</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_181507.2(HPS5):c.739dup (p.Glu247fs)</Name>
      <CanonicalSPDI>NC_000011.10:18306219:CCC:CCCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>11p15.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="18306219" stop="18306220" display_start="18306219" display_stop="18306220" variantLength="1" positionVCF="18306219" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="18327766" stop="18327767" display_start="18327766" display_stop="18327767" variantLength="1" positionVCF="18327766" referenceAlleleVCF="T" alternateAlleleVCF="TC" />
      </Location>
      <ProteinChange>E247fs</ProteinChange>
      <ProteinChange>E133fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_586t1" sequenceAccession="LRG_586t1">
            <Expression>LRG_586t1:c.737dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_586p1" sequenceAccession="LRG_586p1" change="p.Glu247Glyfs">
            <Expression>LRG_586p1:p.Glu247Glyfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_586" sequenceAccession="LRG_586">
            <Expression>LRG_586:g.20955dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.18306222dup" Assembly="GRCh38">
            <Expression>NC_000011.10:g.18306222dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.18327769dup" Assembly="GRCh37">
            <Expression>NC_000011.9:g.18327769dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008877.1" sequenceAccession="NG_008877" sequenceVersion="1" change="g.20955dup">
            <Expression>NG_008877.1:g.20955dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_007216.4" sequenceAccession="NM_007216" sequenceVersion="4" change="c.397dup">
            <Expression>NM_007216.4:c.397dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_009147.3" sequenceAccession="NP_009147" sequenceVersion="3" change="p.Glu133fs">
            <Expression>NP_009147.3:p.Glu133fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181507.2" sequenceAccession="NM_181507" sequenceVersion="2" change="c.739dup" MANESelect="true">
            <Expression>NM_181507.2:c.739dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852608.1" sequenceAccession="NP_852608" sequenceVersion="1" change="p.Glu247fs">
            <Expression>NP_852608.1:p.Glu247fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181508.1" sequenceAccession="NM_181508" sequenceVersion="1" change="c.397dup">
            <Expression>NM_181508.1:c.397dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_852609.1" sequenceAccession="NP_852609" sequenceVersion="1" change="p.Glu133fs">
            <Expression>NP_852609.1:p.Glu133fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_181507.2" sequenceAccession="NM_181507" sequenceVersion="2" change="c.739dupG" MANESelect="true">
            <Expression>NM_181507.2:c.739dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_181507.2(HPS5):c.739dup (p.Glu247fs) AND not provided" Accession="RCV003871666" Version="1">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-14" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_181507.2(HPS5):c.739dup (p.Glu247fs) AND Hermansky-Pudlak syndrome" Accession="RCV003988164" Version="1">
        <ClassifiedConditionList TraitSetID="6264">
          <ClassifiedCondition DB="MedGen" ID="C0079504">Hermansky-Pudlak syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2024-01-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-01-11" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2024-02-29" MostRecentSubmission="2024-03-30">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">12548288</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15296495</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21833017</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26785811</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="6264" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2033" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hermansky-Pudlak syndrome</ElementValue>
                <XRef ID="Hermansky-Pudlak+syndrome/3391" DB="Genetic Alliance" />
                <XRef ID="MONDO:0019312" DB="MONDO" />
                <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
                <XRef ID="9311003" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HPS</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="6643" />
                <XRef ID="6643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Hermansky-Pudlak syndrome (HPS) is characterized by oculocutaneous albinism, a bleeding diathesis, and, in some individuals, pulmonary fibrosis, granulomatous colitis, or immunodeficiency. Ocular findings include reduced iris pigment with iris transillumination, reduced retinal pigment, foveal hypoplasia with significant reduction in visual acuity (usually in the range of 20/50 to 20/400), nystagmus, and increased crossing of the optic nerve fibers. Hair color ranges from white to brown; skin color ranges from white to olive and is usually a shade lighter than that of other family members. The bleeding diathesis can result in variable bruising, epistaxis, gingival bleeding, postpartum hemorrhage, colonic bleeding, and prolonged bleeding with menses or after tooth extraction, circumcision, and other surgeries. Pulmonary fibrosis, a restrictive lung disease, typically causes symptoms in the early thirties and can progress to death within a decade. Granulomatous colitis is severe in about 15% of affected individuals. Neutropenia and/or immune defects occur primarily in individuals with pathogenic variants in AP3B1 and AP3D1.</Attribute>
                <XRef ID="NBK1287" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301464</ID>
                <ID Source="BookShelf">NBK1287</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Skin Cancer">
                <ID Source="PubMed">26389333</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <XRef ID="79430" DB="Orphanet" />
              <XRef ID="C0079504" DB="MedGen" />
              <XRef ID="MONDO:0019312" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS203300" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="8638049" SubmissionDate="2024-02-07" DateLastUpdated="2024-02-28" DateCreated="2024-02-28">
        <ClinVarSubmissionID localKey="11459636|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004682102" DateUpdated="2024-02-28" DateCreated="2024-02-28" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">12548288</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15296495</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21833017</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26785811</ID>
          </Citation>
          <Comment>This variant is present in population databases (rs761811248, gnomAD 0.01%). For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with HPS5-related conditions. This sequence change creates a premature translational stop signal (p.Glu247Glyfs*5) in the HPS5 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HPS5 are known to be pathogenic (PMID: 12548288, 15296495, 21833017, 26785811).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.18327766_18327767insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200269</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="8982440" SubmissionDate="2024-02-19" DateLastUpdated="2024-03-30" DateCreated="2024-03-30">
        <ClinVarSubmissionID localKey="NM_181507.2:c.739dupG|MedGen:C0079504" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004804487" DateUpdated="2024-03-30" DateCreated="2024-03-30" Type="SCV" Version="1" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-01-11">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Variant summary: HPS5 c.739dupG (p.Glu247GlyfsX5) results in a premature termination codon, predicted to cause absence of the protein due to nonsense mediated decay, which is a commonly known mechanism for disease. The variant allele was found at a frequency of 1.6e-05 in 251476 control chromosomes. To our knowledge, no occurrence of c.739dupG in individuals affected with Hermansky-Pudlak Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="HPS5" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_181507.2:c.739dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0079504" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14257878</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="8638049" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="8982440" TraitType="Disease" MappingType="XRef" MappingValue="C0079504" MappingRef="MedGen">
        <MedGen CUI="C0079504" Name="Hermansky-Pudlak syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

